Dark Forest Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-61,220
| Closed | -$101K | – | 1291 |
|
|
2024
Q4 | $101K | Buy |
61,220
+34,371
| +128% | +$56.7K | 0.01% | 862 |
|
|
2024
Q3 | $94K | Buy |
26,849
+7,784
| +41% | +$27.2K | 0.01% | 922 |
|
|
2024
Q2 | $62.5K | Buy |
+19,065
| New | +$62.5K | 0.01% | 629 |
|
|
2023
Q4 | – | Sell |
-425,901
| Closed | -$903K | – | 687 |
|
|
2023
Q3 | $903K | Buy |
425,901
+352,204
| +478% | +$747K | 0.07% | 459 |
|
|
2023
Q2 | $351K | Buy |
73,697
+58,166
| +375% | +$277K | 0.03% | 764 |
|
|
2023
Q1 | $88.5K | Buy |
+15,531
| New | +$88.5K | 0.02% | 699 |
|
|
2022
Q1 | – | Sell |
-216
| Closed | -$13K | – | 1429 |
|
|
2021
Q4 | $13K | Sell |
216
-66
| -23% | -$3.97K | ﹤0.01% | 829 |
|
|
2021
Q3 | $17K | Buy |
+282
| New | +$17K | 0.01% | 868 |
|